1. Home
  2. IMCC vs POLA Comparison

IMCC vs POLA Comparison

Compare IMCC & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • POLA
  • Stock Information
  • Founded
  • IMCC 1980
  • POLA 1979
  • Country
  • IMCC Israel
  • POLA United States
  • Employees
  • IMCC N/A
  • POLA N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • POLA Industrial Machinery/Components
  • Sector
  • IMCC Health Care
  • POLA Miscellaneous
  • Exchange
  • IMCC Nasdaq
  • POLA Nasdaq
  • Market Cap
  • IMCC 5.0M
  • POLA N/A
  • IPO Year
  • IMCC N/A
  • POLA 2016
  • Fundamental
  • Price
  • IMCC $2.23
  • POLA $0.45
  • Analyst Decision
  • IMCC
  • POLA
  • Analyst Count
  • IMCC 0
  • POLA 0
  • Target Price
  • IMCC N/A
  • POLA N/A
  • AVG Volume (30 Days)
  • IMCC 11.8K
  • POLA 454.1K
  • Earning Date
  • IMCC 11-11-2024
  • POLA 11-12-2024
  • Dividend Yield
  • IMCC N/A
  • POLA N/A
  • EPS Growth
  • IMCC N/A
  • POLA N/A
  • EPS
  • IMCC N/A
  • POLA N/A
  • Revenue
  • IMCC $36,445,402.00
  • POLA $11,950,000.00
  • Revenue This Year
  • IMCC $22.59
  • POLA $6.72
  • Revenue Next Year
  • IMCC $20.53
  • POLA N/A
  • P/E Ratio
  • IMCC N/A
  • POLA N/A
  • Revenue Growth
  • IMCC N/A
  • POLA N/A
  • 52 Week Low
  • IMCC $1.13
  • POLA $0.32
  • 52 Week High
  • IMCC $8.10
  • POLA $0.98
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 41.06
  • POLA 49.24
  • Support Level
  • IMCC $2.02
  • POLA $0.44
  • Resistance Level
  • IMCC $2.15
  • POLA $0.54
  • Average True Range (ATR)
  • IMCC 0.14
  • POLA 0.07
  • MACD
  • IMCC -0.01
  • POLA -0.01
  • Stochastic Oscillator
  • IMCC 19.15
  • POLA 20.00

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: